SUTRO BIOPHARMA INC.
0,8838
23-мая-25 09:09:39
15 мин. задержка
Акции
-0,0188
-2,08%
Сегодняшний диапазон
0,8503 - 0,9000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
08 май 2025 13:31:42 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma to Participate in Upcoming Investor Conferences
01 май 2025 13:05:00 Источник Nasdaq GlobeNewswire
-
28 апр 2025 13:05:00 Источник Nasdaq GlobeNewswire
-
15 мар 2025 15:40:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
13 мар 2025 13:07:00 Источник Nasdaq GlobeNewswire
-
13 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
03 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 янв 2025 13:05:03 Источник Nasdaq GlobeNewswire
-
07 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
-
10 дек 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights
13 ноя 2024 13:30:00 Источник Nasdaq GlobeNewswire
-
04 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire
-
01 ноя 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum
10 окт 2024 13:05:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 сен 2024 13:01:00 Источник Nasdaq GlobeNewswire
-
14 сен 2024 00:00:00 Источник Nasdaq GlobeNewswire
-
11 сен 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
22 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
13 авг 2024 13:30:00 Источник Nasdaq GlobeNewswire
-
Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer
09 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >